Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors von Razak, Albiruni RA, Cleary, James M, Moreno, Victor, Boyer, Michael, Calvo Aller, Emiliano, Edenfield, William, Tie, Jeanne, Harvey, R Donald, Rutten, Annemie, Shah, Manish A, Olszanski, Anthony J, Jäger, Dirk, Lakhani, Nehal, Ryan, David P, Rasmussen, Erik, Juan, Gloria, Wong, Hansen, Soman, Neelesh, Smit, Marie-Anne Damiette, Nagorsen, Dirk, Papadopoulos, Kyriakos P

Volltext

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain von Calvo Aller, Emiliano, Maroto, Pablo, Kreif, Noémi, González Larriba, José Luis, López-Brea, Marta, Castellano, Daniel, Martí, Belén, Díaz Cerezo, Silvia

Volltext

794 Safety and efficacy results from a phase 1/1b study of intratumoral MK-4621, a retinoic acid-inducible gene I (RIG-I) agonist, plus intravenous pembrolizumab in patients with a... von Moreno, Victor, Gaudy-Marqueste, Caroline, Wermke, Martin, Italiano, Antoine, Romano, Emanuela, Marabelle, Aurelien, Connors, Emilee, Zhou, Heng, Dobrenkov, Konstantin, Chartash, Elliot, Calvo, Emiliano, Emiliano Calvo Aller

Volltext

589 Xevinapant plus nivolumab in patients with advanced solid tumors who progressed on prior anti–PD-1/PD-L1 treatment: results of a dose-optimization, exploratory phase 1b/2 trial... von Emiliano Calvo Aller, Hanna, Glenn, Maria Vieito Villar, Even, Caroline, Moreno, Victor, Kim, Chul, Gulati, Shuchi, Morgensztern, Daniel, Acuna-Villaorduna, Ana, Cassier, Philippe, Jones, Dennie, Bouisset, Florilene, Sahlender, Daniela, Rouits, Elisabeth, Spaggiari, Dany, Damstrup, Lars, Gomez-Roca, Carlos-Alberto

Volltext

Abstract CT110: Safety and anti-tumor activity of a novel Treg depleter RG6292, as a single agent and in combination with atezolizumab in patients with solid tumors von Gambardella, Valentina, Ong, Michael, Ruiz, Maria Esperanza Rodriguez, Machiels, Jean-Pascal, de Sanmamed, Miguel Fernandez, Tabernero, Josep Maria, Spreafico, Anna, Renouf, Daniel J, Luen, Stephen J, Galot, Rachel, de Speville Uribe, Bernard Doger, Aller, Emiliano Calvo, Naing, Aung, Curdt, Samira, Rossmann, Eva, Tanos, Tamara, Smart, Kevin, Amann, Maria, Xie, Yuying, Schnetzler, Gabriel, Boetsch, Christophe, Karanikas, Vaios, Kolben, Theresa, Xu, Linxinyu, Rohrberg, Kristoffer S

Volltext

Abstract CT257: First-in-human phase 1 studies of PTPN2/1 inhibitors ABBV-CLS-484 and ABBV-CLS-579 in locally advanced or metastatic tumors von LoRusso, Patricia M., Aller, Emiliano Calvo, Yamamoto, Noboru, Lin, Chia-Chi, Beck, Thaddeus, Sommerhalder, David, Oh, Do-Youn, Powderly, John D., Golan, Talia, Abraham, Linu Sara, Hayflick, Joel S., Uziel, Tamar, Brunsdon, Priya, Munasinghe, Wijith, Paddock, Marcia, Hartman, Cathleen Brdlik, Powell, Jonathan, Medeiros, Bruno, Neagu, Martha R., Carneiro, Benedito A.

Volltext